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Materials
Chloroacetyl chloride, di-t-butyl dicarbonate, ethane-1,2-diamine, ethyl bromoacetate, TFA, piperidine, EDC and silica gel (100-200 mesh) were purchased from Spectrochem, India. Dry DMF and dry dichloromethane were purchased from Rankem, India. Acetic anhydride was purchased from Thomas Baker, India. 5-Iodouracil, sodium ascorbate, propargylamine, tetrakis (triphenylphosphine) palladium (0), pyridine, N-hydroxybenzotriazole (HOBt), 3-[bis(dimethylamino)methyliumyl]-3H-benzotriazol-1-oxide hexafluorophosphate (HBTU), N,N-diisopropylethylamine (DIPEA), 1,2-ethanedithiol, thioanisole, anisole, Fmoc-Lys(Boc)-OH and trifluoromethanesulfonic acid (TFMSA), vanadyl ribonucleoside complex (VRC, RNase inhibitor) solution, paraformaldehyde, dextran sulphate, formamide, salmon sperm DNA, RNase A and DAPI were purchased from Sigma-Aldrich. Chemicals for preparing buffer solutions were obtained from Sigma-Aldrich. 5-Iodouracil PNA ester 1 [S1] and 4-ethynyl-1,8-naphthalimide derivative 2 [S2] were synthesized by using our reported procedure. Boc-and Fmoc-protected aeg-PNA monomers and Fmoc PNA backbone d were purchased from ASM Research Chemicals. 4-Methylbenzhydrylamine•HCl (MBHA) resin LL (100-200 mesh) and Boc-Lys(2-Cl-Z)-OH were obtained from Novabiochem. Rink amide AM resin (100-200 mesh) was purchased from GL Biochem (Shanghai) Ltd. DNA ONs were purchased from Integrated DNA Technologies. Custom synthesized RNA ON purchased from Dharmacon RNAi Technologies was deprotected according to the supplier's procedure. Reagents for cell culture experiments such as RPMI1640 and DMEM medium (gibco®), fetal bovine serum (gibco®) and penicillin streptomycin (gibco®) and anti-fade mounting media were obtained from Life Technology, India. 5-Fluorescent Cy5 oligo-dT probe (Cy5-(dT) 30 ) was purchased from Sigma-Aldrich. ATP, GTP, CTP, UTP, RNase inhibitor (Ribolock) were purchased from Thermo Scientific. Taq DNA polymerase (Cat#RR310Q), DNase-1 enzyme (Cat#2270A) and RNAiso plus reagent (Cat#9108) were obtained from Takara™ Clontech. Isopropanol (Cat#13825), chloroform (Cat#22465) for RNA purification was bought from Fisher Scientific. Agarose SeaKem® LE Agarose (Cat#50004) was purchased from Lonza. Gel purification and PCR clean-up kit (Cat#740609.50) were purchased from Macherey Nagel. All ONs were purified by polyacrylamide gel electrophoresis (PAGE) under denaturing conditions and desalted using Sep-Pak Classic C18 cartridges (Waters Corporation). Autoclaved water was used in all biochemical reactions and fluorescence measurements.
Instrumentation
NMR spectra were recorded on a 400 MHz Jeol ECS-400 spectrometer ( 1 H 400 MHz and 13 C 100 MHz) and processed in Mnova NMR software from Mestrelab Research. Mass measurements were recorded on an Applied Biosystems 4800 Plus MALDI-TOF/TOF analyzer instrument and Water Synapt G2 High Definition mass spectrometers. Reversephase (RP) flash chromatography (C18 RediSepRf column) purifications were carried out using Teledyne ISCO, Combi Flash Rf. Microwave reactions were performed using CEM discover microwave synthesizer. PNA oligomers were purified by using Agilent Technologies 1260 Infinity HPLC. Absorption spectra were recorded on a Shimadzu UV-2600 spectrophotometer. UV-thermal melting analysis of duplexes was performed on a Cary 300Bio UV-Vis spectrophotometer. Steady-state fluorescence experiments were carried out in a microfluorescence cuvette (Hellma, path length 1.0 cm) on a Fluoromax-4 and Fluorolog-3 spectrophotometer (Horibha Scientific). Time-resolved fluorescence experiments were carried out on a TCSPC instrument (Horiba JobinYvon, Fluorolog 3). All CD spectra were recorded on JASCO J-815 CD spectrometer. Confocal imaging was carried out on a Zeiss LSM710 Confocal Laser Scanning Microscope with oil immersion using 40X lens.
(mi.) and 166.9 (ma.), 164.1 (mi.) and 163.8 (ma.), 161.6, 156.2, 149.9, 148.5 (mi.) and 148.4 (ma.), 133.0, 132.3, 132.2, 131.8, 131.5, 130.3 (ma.) and 130.2 (mi.), 128.7, 128.6, 128.0 (mi.) and 127.8 (ma.), 127.1, 122.7 (ma.) and 122.2 (mi.), 99.7, 91.4, 90.2, 80.3, 72.0, 70.7, 70.6, 70.3, 68.0, 62.6, 62.0, 59.1, 49.4, 49.0, 48.6, 46.2, 39.3 (ma.) To a solution of fluorescent PNA ester 3 (0.45 g, 0.59 mmol, 1.0 equiv.) in 13.5 mL methanol was added 6.75 mL 3% lithium hydroxide solution and the reaction mixture was stirred for 3 h at RT. The solvent was evaporated to dryness, and the residue was dissolved in water and washed with diethyl ether. To the aqueous extract was added saturated KHSO 4 solution to adjust the pH to ~4. The product was then extracted with EtOAc and solvent was evaporated. The residue was purified by reversed phase column chromatography (C18 RediSepRf column, MeOH: H 2 O) to afford the yellow solid 4 (0.3 g, 69% 163.2, 162.9, 161.9, 155.8 (ma.) and 155.6 (mi.), 151.2 (mi.) and 150.9 (ma.), 149.9, 132.1 (ma.) and 131.9 (mi.), 131.5, 131.3, 130.7 (ma.) and 130.6 (mi.), 130.2 (ma.) and 130.0 (mi.), 128.8 (ma.) and 128.7 (mi.), 128.1 (ma.) and 128.0 (mi.), 127.4 (ma.) and 127.3 (mi.), 126.5 (mi.) and 126.4 (ma.), 122.6 (ma.) and 122.5 (mi.), 121.5 (ma.) and 121.4 (mi.), 96.6, 92.3, 89.5, 78.1, 77.7, 71.2, 69.7, 69.6, 66.9, 58.0, 48.4, 47.9, 46.9, 38.0, 28 
N-(2-Aminoethyl)-N-(2-(5-((2-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)ethynyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl)glycine 5:
Solution of compound 4 (0.30 g, 0.41 mmol, 1.0 equiv.) in 50% TFA in dichloromethane (15 mL) was stirred for 3 h at RT. Reaction mixture was evaporated to dryness using NaOH trap, and residue was co-evaporated with dichloromethane (3 x 20 mL). Residue was further purified by RP-HPLC using a semipreparative column [conditions: 050% B in 10 min and 50100% B in 10 min (Mobile phase A: 5% acetonitrile in H 2 O containing 0.1% TFA. Mobile phase B: 100% acetonitrile in H 2 O containing 0.1% TFA) and flow rate: 1 mL/min] to afford yellow solid 5 (0.13 g, 51%). C-NMR (100 MHz, d 6 -DMSO): δ = 170.9 (mi.) and 170.8 (ma.), 168.2, 167.0, 163.2 (mi.) and 162.9 (ma.), 161.9, 151.1, 150.0, 131.9, 131.3, 130.7, 130.2, 130.0, 128.2, 127.4, 126.4, 122.6, 121.6, 96.7 (mi.) and 96.6 (ma.), 92.4 (ma.) and 92.3 (mi.), 89.6 (mi.) and 89.5 (ma.), 71.2, 69.7, 69.6, 66.9, 58.0, 48.8 (mi.) 
Ethyl 2-(5-((2-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)ethynyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetate b:
To a suspension of compound a [S3] (0.610 g, 1.88 mmol, 1.0 equiv.), 2 (0.680 g, 1.88 mmol, 1.0 equiv.), Pd(Ph 3 ) 4 (0.214 g, 0.19 mmol, 0.1 equiv.) and CuI (0.071 g, 0.38 mmol, 0.2 equiv.) in degassed dry THF (6 mL) was added N,N-diisopropylethylamine (1.13 mL, 6.58 mmol, 3.5 equiv.). The reaction mixture was stirred for 12 h at RT and filtered through Celite pad, washed with THF (2 x 10 mL). The filtrate was then evaporated and the residue was washed with petroleum ether (2 x 20 mL). The crude product was further re-crystallized using EtOAc (30 mL) to afford the product b as a yellow solid (0.545 g, 52%). TLC R f = 0.41 (EtOAc); 6, 163.1, 162.8, 161.7, 150.3, 149.8, 131.8, 131.2, 130.6, 130.1, 130.0, 128.0, 127.3, 126.2, 122.5, 121.6, 96.9, 92.0, 89.5, 71.1, 69.6, 69.5, 66.8, 61.4, 57.9, 49.0, 14.0 
2-(5-((2-(2-(2-(2-Methoxyethoxy)ethoxy)ethyl)-1,3-dioxo-2,3-dihydro-1H benzo[de]isoquinolin-6-yl)ethynyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid c:
To a solution of compound b (0.545 g, 0.97 mmol, 1.0 equiv.) in THF (11 mL), lithium hydroxide (7% solution in H 2 O, 5.0 mL) was added dropwise and the reaction mixture was stirred for 2 h at RT. Reaction mixture was evaporated to dryness, and residue was dissolved in water (20 mL) and washed with diethyl ether (15 ml). To the aqueous extract was added saturated KHSO 4 solution (~5 mL) to adjust the pH to ~5 and product was precipitated out as yellow solid, which was further collected upon filtration as a yellow solid c (0.47 g, 91%). TLC R f = 0.18 (CH 2 Cl 2 :MeOH = 8:2); 3.47-3.41 (m, 4H), 3.30-3.27 (m, 2H), 3.14 (s, 3H) ppm; 13 C-NMR (100 MHz, d 6 -DMSO): δ = 169. 1, 165.7, 163.1, 162.8, 161.7, 150.6, 149.9, 131.8, 131.2, 130.6, 130.1, 129.9, 128.0, 127.3, 126.3, 122.5, 121.5, 96.7, 92.2, 89.4, 71.1, 69.6, 69.5, 66.9, 57.9, 49 9, 166.7, 163.1, 162.8, 161.8, 157.4, 150.9, 149.9, 142.5, 139.4, 137.4, 131.9, 131.2, 130.6, 130.1, 129.9, 128.9, 128.0, 127.4, 127.2, 126.4, 122.5, 121.5, 121.3, 120.0, 109.7, 96.6, 92.4, 92.3, 89.4, 82.0, 81.0, 71.1, 69.6, 69.5, 66.9, 57.9, 54.9, 48.7, 48.4, 47.2, 38.8, 27.7 (ma.) Solution of compound e (0.13 g, 0.14 mmol, 1.0 equiv.) in 50% TFA in dichloromethane (15 mL) was stirred for 2 h at RT. Solvent was evaporated to dryness using NaOH trap, and residue was co-evaporated using dichloromethane (3 x 20 mL). Crude product was purified using silica gel column chromatography with dichloromethane and methanol solvent system to afford yellow product f (95 mg, 78%). TLC R f = 0.33 (CH 2 Cl 2 :MeOH = 8.5:1.5); 1 H-NMR (400 MHz, d 6 -DMSO): δ = 11.95 (mi.) and 11.90 (ma.) (br, 1H), 8.69-8.61 (m, 1 H), 8.48-8.24 (m, 3H), 7.84-7.47 (m, 7H), 7.39-7.26 (m, 4H) , 4.83 (mi.) and 4.68 (ma.) (s, 2H), 4. 33-4.13 (m, 5H), 3.99 (br, 2H), 3.66-3.63 (m, 2H), 3.55-3.53 (m, 2H), 3.47-3.45 (m, 3H), 3.43-3.41 (m, 4H), 3.31-3.27 (m, 3H) , 3.15 (ma.) and 3.14 (mi.) (s, 3H) ppm; 13 C-NMR (100 MHz, d 6 -DMSO): δ = 167. 4, 166.5, 163.1, 162.8, 161.9, 156.4, 156.1, 151 .1 (mi.) and 151.0 (ma.), 150.0, 143.8, 140.7, 140.6, 131.9, 131.2, 131.7, 130.6 (mi.) and 130.5 (ma.), 130.1, 130.0, 129.9, 129.8, 129.7, 128.0, 127.9, 127.8, 127.6 (mi.) and 127.5 (ma.), 127.3, 127.1, 126.4, 125.2, 120 .1 (mi.) and 120.0 (ma.), 96.6, 92.5 and 92.4, 89.5, 71.2, 69.7, 69.6, 66.9, 65.6, 58.0, 51.2, 48.6, 46.8 (mi.) 
Photophysical characterization of PNA base analog 5 UV-Vis absorption:
Samples of analog 5 (25.0 µM) were prepared in water, dioxane and their mixtures (25% dioxane, 50% dioxane, 75% dioxane in water). All solutions contained 2.5% DMSO. Steady-state fluorescence: Emission spectra of analog 5 (5.0 µM) in water, dioxane and their mixtures (25% dioxane, 50% dioxane, 75% dioxane in water) were recorded by exciting the samples at respective longest absorption maximum (Table 1) . Excitation and emission slit widths were kept at 1 and 3 nm, respectively. All solutions contained 0.5% DMSO. Time-resolved fluorescence: Excited-state lifetime of Lucifer PNA analog 5 (5.0 μM) in various solvents was determined using TCSPC instrument (Horiba Jobin Yvon, Fluorolog-3). Samples were excited using a 371 nm LED source (IBH, UK, NanoLED-371L) and fluorescence signal at respective emission maximum was collected. Lifetime measurements were performed in duplicate and decay profiles were analyzed using IBH DAS6 analysis software. Fluorescence intensity decay profiles were found to be biexponential with  2 (goodness of fit) values very close to unity.
Quantum yield determination of emissive PNA base analog 5
The quantum yield of emissive PNA analog 5 in different solvents relative to cumarin 153 standard was determined using the following equation.
[S4]
Where s is the standard, x is PNA analog (5), A is the absorbance at excitation wavelength, F is the area under the emission curve, n is the refractive index of the solvent, and Φ F is the quantum yield. Quantum yield of cumarin 153 in acetonitrile is 0.56. Table 1 for details.
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6. Solid-phase synthesis of control unmodified and naphthalimide-modified PNA oligomers Model 15mer control unmodified (69) and fluorescently-modified (6X9X) PNA oligomers were synthesized on MBHA resin using Boc-protected PNA monomers and Boc-protected fluorescent naphthalimide PNA acid 4 (Scheme S1) according to our reported protocol. [S6] Fluorescent poly(T) PNA probe 10 was synthesized by SPPS protocol on Rink amide resin using Fmoc-protected aeg-thymine and fluorescent naphthalimide-modified uracil PNA acid f (Scheme S2). The detailed protocol for the synthesis of poly(T) PNA probe 10 and unmodified poly(T) PNA 13 using Fmoc-chemistry is given below. To enhance aqueous solubility of the PNA oligomers, two lysine residues were attached at the C-terminus of all the PNA oligomers. In a glass sintered flask, Rink-amide resin (250 mg, 0.65 mmol/g) was swelled in CH 2 Cl 2 (8 mL) for 12 h. The solvent was then removed, and the resin was treated with 20% piperidine in DMF (6 mL) for 10 min to remove Fmoc-group from the resin. This step was repeated two more times. The resin was then washed sequentially with DMF (3 x 3 mL), CH 2 Cl 2 (3 x 3 mL), and DMF (3 x 3 mL). The resin was dried under nitrogen flow for few minutes. The coupling reaction was performed in dry DMF (1.8 mL) with Fmoc-Lys(Boc)-OH (36 mg, 1.0 equiv. to obtain a loading of 0.35 mmol/g) in the presence of HOBt (1.0 equiv.), HBTU (1.0 equiv.) and DIPEA (1.0 equiv.) for 7-9 h at RT. The resin was further washed with DMF (3 x 3 mL), CH 2 Cl 2 (3 x 3 mL), and DMF (3 x 3 mL). Next, remaining amino groups on the resin was capped with acetic anhydride (1.0 mL) in pyridine (1.0 mL) for 1 h at RT. This step was repeated two more times, and the resin was then washed with DMF (3 x 3 mL), CH 2 Cl 2 (3 x 3 mL), and DMF (3 x 3 mL) and dried under nitrogen flow for few minutes. The resin was treated with 20% piperidine in DMF (5 mL) for 10 min to remove Fmoc-group. This step was repeated two more times, and the resin was washed with DMF (3 x 3 mL), CH 2 Cl 2 (3 x 3 mL), and DMF (3 x 3 mL). Then coupling reaction was performed in dry DMF (1.8 mL) with Fmoc-Lys(Boc)-OH (3.0 equiv.) in the presence of HOBt (3.0 equiv.), HBTU (3.0 equiv.) and DIPEA (3.0 equiv.) for 7-9 h at RT. The resin was then washed with DMF (3 x 3 mL), CH 2 Cl 2 (3 x 3 mL), and DMF (3 x 3 mL). The resin was dried under nitrogen flow for few minutes.
Above lysine loaded Rink-amide resin (25 mg, 0.35 mmol/g) was swelled in CH 2 Cl 2 (2 mL) for 2 h in glass sintered flask. The solvent was removed and the resin was treated with 20% piperidine in DMF (1.0 mL) for 10 min to remove Fmoc-group as mentioned above. The resin was then washed with DMF (3 x 3 mL), CH 2 Cl 2 (3 x 3 mL), and DMF (3 x 3 mL). The coupling reaction was performed in dry DMF (0.6 mL) with Fmoc-thymine PNA monomer (3.0 equiv.) in the presence of HOBt (3.0 equiv.), HBTU (3.0 equiv.) and DIPEA (3.0 equiv.) for 6 min at 65 °C using microwave peptide synthesizer (Note: coupling reaction for fluorescent PNA monomer f was carried out at RT for 7-9 h). The resin was washed again, and the coupling, Fmoc deprotection, and washing steps were repeated in the cycle as mentioned above to synthesize the desired PNA sequence. Also, a double-coupling reaction was performed for only fluorescently-modified PNA monomer f in the presence of HOBt (3.0 equiv.), HBTU (3.0 equiv.) and DIPEA (3.0 equiv.) for 7-9 h at RT.
Cleavage procedure: The dried resin (20 mg) was transferred to a glass vial and treated with H 2 O (10 L) and anisole (10 L) in an ice bath for 10 min. TFA (380 L) was then added to the above mixture and was stirred for 1.5 h at room temperature. The resin was filtered, and the filtrate was concentrated and precipitated as a white solid by adding cold diethyl ether (1 mL). The solvent was decanted, and the crude product was dissolved in autoclaved water and purified by RP-HPLC.
HPLC analysis of PNA oligomers
All control and fluorescently modified PNA oligomers were purified using a Luna C18 semipreparative RP column (5 micron, 250 × 10 mm, Phenomenex) on an Agilent Technologies 1260 Infinity HPLC system. Conditions: 050% B in 25 min and 50100% B in 15 min (Mobile phase A: 5% acetonitrile in H 2 O containing 0.1% TFA. Mobile phase B: 50% acetonitrile in H 2 O containing 0.1% TFA). Flow rate was 2 mL/min. The chromatogram of control PNA oligomers was recorded at 260 nm, and fluorescently modified PNA oligomers was recorded at 260 nm, and 400 nm. Concentration of the PNA oligomers was determined by using the molar extinction coefficients of nucleobases at 260 nm (ε A = 13700, ε T = 8600, ε G = 11700, ε C = 6600, ε 5 = 9680 M -1 cm -1 ). [S7] 8. MALDI-TOF mass measurement of PNA oligomers 1 μL of a ~150 μM stock solution of PNA oligomer was combined with 2,5-dihydroxybenzoic acid (DHB) or α-cyano-4-hydroxycinnamic acid (CHCA) matrix. The samples were spotted on a plate and air dried before mass analysis. Table S2 . Table S2 . Thermal melting experiments indicated that the modification had discernible destabilization effect on the duplex. However, the Lucifer-modified PNA oligomers formed stable hybrids with complementary ONs under the conditions used for fluorescence analysis. Excitation and emission slit widths were kept at 6 and 8 nm, respectively. PNA oligomers 8X and 9X and their duplexes were found to be very weakly fluorescent. (C) Emission spectra (0.5 µM) of emissive PNA oligomer 7X and PNA-DNA/RNA duplex made of 7X. Excitation and emission slit widths were kept at 6 and 7 nm, respectively. All samples were prepared in 10 mM phosphate buffer (pH 7.1, 100 mM NaCl, 0.1 mM EDTA) and excited at 400 nm. 
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Gel shift assay: A series of solution of Cy5-(dT) 30 (1.0 µM) containing increasing concentrations of poly(A) RNA ON 12 (100 nM to 5 µM) was prepared as mentioned above. The volume of samples was 10 μL. To the samples was added 10 μL of loading buffer (10 mM Tris-HCl, pH 7.2 and 10% glycerol). The samples were loaded onto a 15% nondenaturing polyacrylamide gel containing 100 mM NaCl. A peristaltic pump was used to maintain the ionic conditions in both the chambers. The gel electrophoresis was performed at ~4 C with a constant power supply of 14 W for ~10 h. The bands were visualized by using Typhoon-TRIO+ imager by illuminating the gel using fluorescence of Cy5. The bands were quantified using GeneTools image analysis software (Syngene) and K d was determined as explained below. 
